114 STAT. 1101 PUBLIC LAW 106–310—OCT. 17, 2000
Public Law 106–310
106th Congress
An Act
To amend the Public Health Service Act with respect to children’s health.
Be it enacted by the Senate and House of Representatives of
the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘‘Children’s Health Act of 2000’’.
SEC. 2. TABLE OF CONTENTS.
The table of contents for this Act is as follows:
Sec.1. Short title.
Sec.2.Table of contents.
DIVISION A—CHILDREN’S HEALTH
TITLE I—AUTISM
Sec.101.Expansion, intensification, and coordination of activities of National Institutes
of Health with respect to research on autism.
Sec.102.Developmental disabilities surveillance and research programs.
Sec.103.Information and education.
Sec.104.Inter-agency Autism Coordinating Committee.
Sec.105.Report to Congress.
TITLE II—RESEARCH AND DEVELOPMENT REGARDING FRAGILE X
Sec.201.National Institute of Child Health and Human Development; research on
fragile X.
TITLE III—JUVENILE ARTHRITIS AND RELATED CONDITIONS
Sec.301.National Institute of Arthritis and Musculoskeletal and Skin Diseases;
research on juvenile arthritis and related conditions.
Sec.302.Information clearinghouse.
TITLE IV—REDUCING BURDEN OF DIABETES AMONG CHILDREN AND
YOUTH
Sec.401.Programs of Centers for Disease Control and Prevention.
Sec.402.Programs of National Institutes of Health.
TITLE V—ASTHMA SERVICES FOR CHILDREN
Subtitle A—Asthma Services
Sec.501.Grants for children’s asthma relief.
Sec.502.Technical and conforming amendments.
Subtitle B—Prevention Activities
Sec.511.Preventive health and health services block grant; systems for reducing
asthma-related illnesses through integrated pest management.
Subtitle C—Coordination of Federal Activities
Sec.521.Coordination through National Institutes of Health.
Subtitle D—Compilation of Data
Sec.531.Compilation of data by Centers for Disease Control and Prevention.
42 USC 201 note.
Children’s Health
Act of 2000.
Oct. 17, 2000
[H.R. 4365]
VerDate 11-MAY-2000 20:31 Oct 27, 2000 Jkt 089139 PO 00310 Frm 00001 Fmt 6580 Sfmt 6582 E:\PUBLAW\PUBL310.106 APPS24 PsN: PUBL310
114 STAT. 1102 PUBLIC LAW 106–310—OCT. 17, 2000
TITLE VI—BIRTH DEFECTS PREVENTION ACTIVITIES
Subtitle A—Folic Acid Promotion
Sec.601.Program regarding effects of folic acid in prevention of birth defects.
Subtitle B—National Center on Birth Defects and Developmental Disabilities
Sec.611.National Center on Birth Defects and Developmental Disabilities.
TITLE VII—EARLY DETECTION, DIAGNOSIS, AND TREATMENT REGARDING
HEARING LOSS IN INFANTS
Sec.701.Purposes.
Sec.702.Programs of Health Resources and Services Administration, Centers for
Disease Control and Prevention, and National Institutes of Health.
TITLE VIII—CHILDREN AND EPILEPSY
Sec.801.National public health campaign on epilepsy; seizure disorder demonstration
projects in medically underserved areas.
TITLE IX—SAFE MOTHERHOOD; INFANT HEALTH PROMOTION
Subtitle A—Safe Motherhood Prevention Research
Sec.901.Prevention research and other activities.
Subtitle B—Pregnant Women and Infants Health Promotion
Sec.911.Programs regarding prenatal and postnatal health.
TITLE X—PEDIATRIC RESEARCH INITIATIVE
Sec.1001.Establishment of pediatric research initiative.
Sec.1002.Investment in tomorrow’s pediatric researchers.
Sec.1003.Review of regulations.
Sec.1004.Long-term child development study.
TITLE XI—CHILDHOOD MALIGNANCIES
Sec.1101.Programs of Centers for Disease Control and Prevention and National Institutes
of Health.
TITLE XII—ADOPTION AWARENESS
Subtitle A—Infant Adoption Awareness
Sec.1201.Grants regarding infant adoption awareness.
Subtitle B—Special Needs Adoption Awareness
Sec.1211.Special needs adoption programs; public awareness campaign and other
activities.
TITLE XIII—TRAUMATIC BRAIN INJURY
Sec.1301.Programs of Centers for Disease Control and Prevention.
Sec.1302.Study and monitor incidence and prevalence.
Sec.1303.Programs of National Institutes of Health.
Sec.1304.Programs of Health Resources and Services Administration.
Sec.1305.State grants for protection and advocacy services.
Sec.1306.Authorization of appropriations for certain programs.
TITLE XIV—CHILD CARE SAFETY AND HEALTH GRANTS
Sec.1401.Definitions.
Sec.1402.Authorization of appropriations.
Sec.1403.Programs.
Sec.1404.Amounts reserved; allotments.
Sec.1405.State applications.
Sec.1406.Use of funds.
Sec.1407.Reports.
TITLE XV—HEALTHY START INITIATIVE
Sec.1501.Continuation of healthy start program.
TITLE XVI—ORAL HEALTH PROMOTION AND DISEASE PREVENTION
Sec.1601.Identification of interventions that reduce the burden and transmission of
oral, dental, and craniofacial diseases in high risk populations; development
of approaches for pediatric oral and craniofacial assessment.
VerDate 11-MAY-2000 20:31 Oct 27, 2000 Jkt 089139 PO 00310 Frm 00002 Fmt 6580 Sfmt 6582 E:\PUBLAW\PUBL310.106 APPS24 PsN: PUBL310
114 STAT. 1103 PUBLIC LAW 106–310—OCT. 17, 2000
Sec.1602.Oral health promotion and disease prevention.
Sec.1603.Coordinated program to improve pediatric oral health.
TITLE XVII—VACCINE-RELATED PROGRAMS
Subtitle A—Vaccine Compensation Program
Sec.1701.Content of petitions.
Subtitle B—Childhood Immunizations
Sec.1711.Childhood immunizations.
TITLE XVIII—HEPATITIS C
Sec.1801.Surveillance and education regarding hepatitis C.
TITLE XIX—NIH INITIATIVE ON AUTOIMMUNE DISEASES
Sec.1901.Autoimmune diseases; initiative through Director of National Institutes of
Health.
TITLE XX—GRADUATE MEDICAL EDUCATION PROGRAMS IN CHILDREN’S
HOSPITALS
Sec.2001.Provisions to revise and extend program.
TITLE XXI—SPECIAL NEEDS OF CHILDREN REGARDING ORGAN
TRANSPLANTATION
Sec.2101.Organ Procurement and Transplantation Network; amendments regarding
needs of children.
TITLE XXII—MUSCULAR DYSTROPHY RESEARCH
Sec.2201.Muscular dystrophy research.
TITLE XXIII—CHILDREN AND TOURETTE SYNDROME AWARENESS
Sec.2301.Grants regarding Tourette Syndrome.
TITLE XXIV—CHILDHOOD OBESITY PREVENTION
Sec.2401.Programs operated through the Centers for Disease Control and
Prevention.
TITLE XXV—EARLY DETECTION AND TREATMENT REGARDING
CHILDHOOD LEAD POISONING
Sec.2501.Centers for Disease Control and Prevention efforts to combat childhood
lead poisoning.
Sec.2502.Grants for lead poisoning related activities.
Sec.2503.Training and reports by the Health Resources and Services
Administration.
Sec.2504.Screenings, referrals, and education regarding lead poisoning.
TITLE XXVI—SCREENING FOR HERITABLE DISORDERS
Sec.2601.Program to improve the ability of States to provide newborn and child
screening for heritable disorders.
TITLE XXVII—PEDIATRIC RESEARCH PROTECTIONS
Sec.2701.Requirement for additional protections for children involved in research.
TITLE XXVIII—MISCELLANEOUS PROVISIONS
Sec.2801.Report regarding research on rare diseases in children.
Sec.2802.Study on metabolic disorders.
TITLE XXIX—EFFECTIVE DATE
Sec.2901.Effective date.
DIVISION B—YOUTH DRUG AND MENTAL HEALTH SERVICES
Sec.3001.Short title.
TITLE XXXI—PROVISIONS RELATING TO SERVICES FOR CHILDREN AND
ADOLESCENTS
Sec.3101.Children and violence.
Sec.3102.Emergency response.
VerDate 11-MAY-2000 20:31 Oct 27, 2000 Jkt 089139 PO 00310 Frm 00003 Fmt 6580 Sfmt 6582 E:\PUBLAW\PUBL310.106 APPS24 PsN: PUBL310
114 STAT. 1104 PUBLIC LAW 106–310—OCT. 17, 2000
Sec.3103.High risk youth reauthorization.
Sec.3104.Substance abuse treatment services for children and adolescents.
Sec.3105.Comprehensive community services for children with serious emotional
disturbance.
Sec.3106.Services for children of substance abusers.
Sec.3107.Services for youth offenders.
Sec.3108.Grants for strengthening families through community partnerships.
Sec.3109.Programs to reduce underage drinking.
Sec.3110.Services for individuals with fetal alcohol syndrome.
Sec.3111.Suicide prevention.
Sec.3112.General provisions.
TITLE XXXII—PROVISIONS RELATING TO MENTAL HEALTH
Sec.3201.Priority mental health needs of regional and national significance.
Sec.3202.Grants for the benefit of homeless individuals.
Sec.3203.Projects for assistance in transition from homelessness.
Sec.3204.Community mental health services performance partnership block grant.
Sec.3205.Determination of allotment.
Sec.3206.Protection and Advocacy for Mentally Ill Individuals Act of 1986.
Sec.3207.Requirement relating to the rights of residents of certain facilities.
Sec.3208.Requirement relating to the rights of residents of certain non-medical,
community-based facilities for children and youth.
Sec.3209.Emergency mental health centers.
Sec.3210.Grants for jail diversion programs.
Sec.3211.Improving outcomes for children and adolescents through services integration
between child welfare and mental health services.
Sec.3212.Grants for the integrated treatment of serious mental illness and
co-occurring substance abuse.
Sec.3213.Training grants.
TITLE XXXIII—PROVISIONS RELATING TO SUBSTANCE ABUSE
Sec.3301.Priority substance abuse treatment needs of regional and national
significance.
Sec.3302.Priority substance abuse prevention needs of regional and national
significance.
Sec.3303.Substance abuse prevention and treatment performance partnership block
grant.
Sec.3304.Determination of allotments.
Sec.3305.Nondiscrimination and institutional safeguards for religious providers.
Sec.3306.Alcohol and drug prevention or treatment services for Indians and
Native Alaskans.
Sec.3307.Establishment of commission.
TITLE XXXIV—PROVISIONS RELATING TO FLEXIBILITY AND
ACCOUNTABILITY
Sec.3401.General authorities and peer review.
Sec.3402.Advisory councils.
Sec.3403.General provisions for the performance partnership block grants.
Sec.3404.Data infrastructure projects.
Sec.3405.Repeal of obsolete addict referral provisions.
Sec.3406.Individuals with co-occurring disorders.
Sec.3407.Services for individuals with co-occurring disorders.
TITLE XXXV—WAIVER AUTHORITY FOR PHYSICIANS WHO DISPENSE OR
PRESCRIBE CERTAIN NARCOTIC DRUGS FOR MAINTENANCE
TREATMENT OR DETOXIFICATION TREATMENT
Sec.3501.Short title.
Sec.3502.Amendment to Controlled Substances Act.
TITLE XXXVI—METHAMPHETAMINE AND OTHER CONTROLLED
SUBSTANCES
Sec.3601.Short title.
Subtitle A—Methamphetamine Production, Trafficking, and Abuse
PART I—CRIMINAL PENALTIES
Sec.3611.Enhanced punishment of amphetamine laboratory operators.
Sec.3612.Enhanced punishment of amphetamine or methamphetamine laboratory
operators.
VerDate 11-MAY-2000 20:31 Oct 27, 2000 Jkt 089139 PO 00310 Frm 00004 Fmt 6580 Sfmt 6582 E:\PUBLAW\PUBL310.106 APPS24 PsN: PUBL310
114 STAT. 1105 PUBLIC LAW 106–310—OCT. 17, 2000
Sec.3613.Mandatory restitution for violations of Controlled Substances Act and Controlled
Substances Import and Export Act relating to amphetamine and
methamphetamine.
Sec.3614.Methamphetamine paraphernalia.
PART II—ENHANCED LAW ENFORCEMENT
Sec.3621.Environmental hazards associated with illegal manufacture of
amphetamine and methamphetamine.
Sec.3622.Reduction in retail sales transaction threshold for non-safe harbor
products containing pseudoephedrine or phenylpropanolamine.
Sec.3623.Training for Drug Enforcement Administration and State and local law
enforcement personnel relating to clandestine laboratories.
Sec.3624.Combating methamphetamine and amphetamine in high intensity drug
trafficking areas.
Sec.3625.Combating amphetamine and methamphetamine manufacturing and trafficking.
PART III—ABUSE PREVENTION AND TREATMENT
Sec.3631.Expansion of methamphetamine research.
Sec.3632.Methamphetamine and amphetamine treatment initiative by Center for
Substance Abuse Treatment.
Sec.3633.Study of methamphetamine treatment.
PART IV—REPORTS
Sec.3641.Reports on consumption of methamphetamine and other illicit drugs in
rural areas, metropolitan areas, and consolidated metropolitan areas.
Sec.3642.Report on diversion of ordinary, over-the-counter pseudoephedrine and
phenylpropanolamine products.
Subtitle B—Controlled Substances Generally
Sec.3651.Enhanced punishment for trafficking in list I chemicals.
Sec.3652.Mail order requirements.
Sec.3653.Theft and transportation of anhydrous ammonia for purposes of illicit production
of controlled substances.
Subtitle C—Ecstasy Anti-Proliferation Act of 2000
Sec.3661.Short title.
Sec.3662.Findings.
Sec.3663.Enhanced punishment of Ecstasy traffickers.
Sec.3664.Emergency authority to United States Sentencing Commission.
Sec.3665.Expansion of Ecstasy and club drugs abuse prevention efforts.
Subtitle D—Miscellaneous
Sec.3671.Antidrug messages on Federal Government Internet websites.
Sec.3672.Reimbursement by Drug Enforcement Administration of expenses
incurred to remediate methamphetamine laboratories.
Sec.3673.Severability.
DIVISION A—CHILDREN’S HEALTH
TITLE I—AUTISM
SEC. 101. EXPANSION, INTENSIFICATION, AND COORDINATION OF
ACTIVITIES OF NATIONAL INSTITUTES OF HEALTH WITH
RESPECT TO RESEARCH ON AUTISM.
Part B of title IV of the Public Health Service Act (42 U.S.C.
284 et seq.) is amended by adding at the end the following section:
‘‘EXPANSION, INTENSIFICATION, AND COORDINATION OF ACTIVITIES OF
NATIONAL INSTITUTES OF HEALTH WITH RESPECT TO RESEARCH ON
AUTISM
‘‘SEC. 409C. (a) IN GENERAL.—
‘‘(1) EXPANSION OF ACTIVITIES.—The Director of NIH (in
this section referred to as the ‘Director’) shall expand, intensify,
42 USC 284g.
VerDate 11-MAY-2000 20:31 Oct 27, 2000 Jkt 089139 PO 00310 Frm 00005 Fmt 6580 Sfmt 6581 E:\PUBLAW\PUBL310.106 APPS24 PsN: PUBL310
114 STAT. 1106 PUBLIC LAW 106–310—OCT. 17, 2000
and coordinate the activities of the National Institutes of Health
with respect to research on autism.
‘‘(2) ADMINISTRATION OF PROGRAM; COLLABORATION AMONG
AGENCIES.—The Director shall carry out this section acting
through the Director of the National Institute of Mental Health
and in collaboration with any other agencies that the Director
determines appropriate.
‘‘(b) CENTERS OF EXCELLENCE.—
‘‘(1) IN GENERAL.—The Director shall under subsection
(a)(1) make awards of grants and contracts to public or nonprofit
private entities to pay all or part of the cost of planning,
establishing, improving, and providing basic operating support
for centers of excellence regarding research on autism.
‘‘(2) RESEARCH.—Each center under paragraph (1) shall
conduct basic and clinical research into autism. Such research
should include investigations into the cause, diagnosis, early
detection, prevention, control, and treatment of autism. The
centers, as a group, shall conduct research including the fields
of developmental neurobiology, genetics, and
psychopharmacology.
‘‘(3) SERVICES FOR PATIENTS.—
‘‘(A) IN GENERAL.—A center under paragraph (1) may
expend amounts provided under such paragraph to carry
out a program to make individuals aware of opportunities
to participate as subjects in research conducted by the
centers.
‘‘(B) REFERRALS AND COSTS.—A program under
subparagraph (A) may, in accordance with such criteria
as the Director may establish, provide to the subjects
described in such subparagraph, referrals for health and
other services, and such patient care costs as are required
for research.
‘‘(C) AVAILABILITY AND ACCESS.—The extent to which
a center can demonstrate availability and access to clinical
services shall be considered by the Director in decisions
about awarding grants to applicants which meet the scientific
criteria for funding under this section.
‘‘(4) COORDINATION OF CENTERS; REPORTS.—The Director
shall, as appropriate, provide for the coordination of information
among centers under paragraph (1) and ensure regular communication
between such centers, and may require the periodic
preparation of reports on the activities of the centers and
the submission of the reports to the Director.
‘‘(5) ORGANIZATION OF CENTERS.—Each center under paragraph
(1) shall use the facilities of a single institution, or
be formed from a consortium of cooperating institutions,
meeting such requirements as may be prescribed by the
Director.
‘‘(6) NUMBER OF CENTERS; DURATION OF SUPPORT.—
‘‘(A) IN GENERAL.—The Director shall provide for the
establishment of not less than five centers under paragraph
(1).
‘‘(B) DURATION.—Support for a center established
under paragraph (1) may be provided under this section
for a period of not to exceed 5 years. Such period may
be extended for one or more additional periods not
exceeding 5 years if the operations of such center have
Grants.
Contracts.
VerDate 11-MAY-2000 20:31 Oct 27, 2000 Jkt 089139 PO 00310 Frm 00006 Fmt 6580 Sfmt 6581 E:\PUBLAW\PUBL310.106 APPS24 PsN: PUBL310
114 STAT. 1107 PUBLIC LAW 106–310—OCT. 17, 2000
been reviewed by an appropriate technical and scientific
peer review group established by the Director and if such
group has recommended to the Director that such period
should be extended.
‘‘(c) FACILITATION OF RESEARCH.—The Director shall under subsection
(a)(1) provide for a program under which samples of tissues
and genetic materials that are of use in research on autism are
donated, collected, preserved, and made available for such research.
The program shall be carried out in accordance with accepted
scientific and medical standards for the donation, collection, and
preservation of such samples.
‘‘(d) PUBLIC INPUT.—The Director shall under subsection (a)(1)
provide for means through which the public can obtain information
on the existing and planned programs and activities of the National
Institutes of Health with respect to autism and through which
the Director can receive comments from the public regarding such
programs and activities.
‘‘(e) FUNDING.—There are authorized to be appropriated such
sums as may be necessary to carry out this section. Amounts
appropriated under this subsection are in addition to any other
amounts appropriated for such purpose.’’.
SEC. 102. DEVELOPMENTAL DISABILITIES SURVEILLANCE AND
RESEARCH PROGRAMS.
(a) NATIONAL AUTISM AND PERVASIVE DEVELOPMENTAL DISABILITIES
SURVEILLANCE PROGRAM.—
(1) IN GENERAL.—The Secretary of Health and Human
Services (in this section referred to as the ‘‘Secretary’’), acting
through the Director of the Centers for Disease Control and
Prevention, may make awards of grants and cooperative agreements
for the collection, analysis, and reporting of data on
autism and pervasive developmental disabilities. In making
such awards, the Secretary may provide direct technical assistance
in lieu of cash.
(2) ELIGIBILITY.—To be eligible to receive an award under
paragraph (1) an entity shall be a public or nonprofit private
entity (including health departments of States and political
subdivisions of States, and including universities and other
educational entities).
(b) CENTERS OF EXCELLENCE IN AUTISM AND PERVASIVE
DEVELOPMENTAL DISABILITIES EPIDEMIOLOGY.—
(1) IN GENERAL.—The Secretary, acting through the
Director of the Centers for Disease Control and Prevention,
shall establish not less than three regional centers of excellence
in autism and pervasive developmental disabilities epidemiology
for the purpose of collecting and analyzing information
on the number, incidence, correlates, and causes of autism
and related developmental disabilities.
(2) RECIPIENTS OF AWARDS FOR ESTABLISHMENT OF CENTERS.
—Centers under paragraph (1) shall be established and
operated through the awarding of grants or cooperative agreements
to public or nonprofit private entities that conduct
research, including health departments of States and political
subdivisions of States, and including universities and other
educational entities.
(3) CERTAIN REQUIREMENTS.—An award for a center under
paragraph (1) may be made only if the entity involved submits
42 USC 247b–4b.
Appropriation
authorization.
VerDate 11-MAY-2000 20:31 Oct 27, 2000 Jkt 089139 PO 00310 Frm 00007 Fmt 6580 Sfmt 6581 E:\PUBLAW\PUBL310.106 APPS24 PsN: PUBL310
114 STAT. 1108 PUBLIC LAW 106–310—OCT. 17, 2000
to the Secretary an application containing such agreements
and information as the Secretary may require, including an
agreement that the center involved will operate in accordance
with the following:
(A) The center will collect, analyze, and report autism
and pervasive developmental disabilities data according
to guidelines prescribed by the Director, after consultation
with relevant State and local public health officials, private
sector developmental disability researchers, and advocates
for those with developmental disabilities.
(B) The center will assist with the development and
coordination of State autism and pervasive developmental
disabilities surveillance efforts within a region.
(C) The center will identify eligible cases and controls
through its surveillance systems and conduct research into
factors which may cause autism and related developmental
disabilities.
(D) The center will develop or extend an area of special
research expertise (including genetics, environmental exposure
to contaminants, immunology, and other relevant
research specialty areas).
(c) CLEARINGHOUSE.—The Secretary, acting through the
Director of the Centers for Disease Control and Prevention, shall
carry out the following:
(1) The Secretary shall establish a clearinghouse within
the Centers for Disease Control and Prevention for the collection
and storage of data generated from the monitoring programs
established by this title. Through the clearinghouse,
such Centers shall serve as the coordinating agency for autism
and pervasive developmental disabilities surveillance activities.
The functions of such a clearinghouse shall include facilitating
the coordination of research and policy development relating
to the epidemiology of autism and other pervasive developmental
disabilities.
(2) The Secretary shall coordinate the Federal response
to requests for assistance from State health department officials
regarding potential or alleged autism or developmental disability
clusters.
(d) DEFINITION.—In this title, the term ‘‘State’’ means each
of the several States, the District of Columbia, the Commonwealth
of Puerto Rico, American Samoa, Guam, the Commonwealth of
the Northern Mariana Islands, the Virgin Islands, and the Trust
Territory of the Pacific Islands.
(e) AUTHORIZATION OF APPROPRIATIONS.—There are authorized
to be appropriated such sums as may be necessary to carry out
this section.
SEC. 103. INFORMATION AND EDUCATION.
(a) IN GENERAL.—The Secretary shall establish and implement
a program to provide information and education on autism to health
professionals and the general public, including information and
education on advances in the diagnosis and treatment of autism
and training and continuing education through programs for scientists,
physicians, and other health professionals who provide care
for patients with autism.
42 USC 247b–4c.
VerDate 11-MAY-2000 20:31 Oct 27, 2000 Jkt 089139 PO 00310 Frm 00008 Fmt 6580 Sfmt 6581 E:\PUBLAW\PUBL310.106 APPS24 PsN: PUBL310
114 STAT. 1109 PUBLIC LAW 106–310—OCT. 17, 2000
(b) STIPENDS.—The Secretary may use amounts made available
under this section to provide stipends for health professionals who
are enrolled in training programs under this section.
(c) AUTHORIZATION OF APPROPRIATIONS.—There are authorized
to be appropriated such sums as may be necessary to carry out
this section.
SEC. 104. INTER-AGENCY AUTISM COORDINATING COMMITTEE.
(a) ESTABLISHMENT.—The Secretary shall establish a committee
to be known as the ‘‘Autism Coordinating Committee’’ (in this
section referred to as the ‘‘Committee’’) to coordinate all efforts
within the Department of Health and Human Services concerning
autism, including activities carried out through the National
Institutes of Health and the Centers for Disease Control and
Prevention under this title (and the amendment made by this
title).
(b) MEMBERSHIP.—
(1) IN GENERAL.—The Committee shall be composed of the
Directors of such national research institutes, of the Centers
for Disease Control and Prevention, and of such other agencies
and such other officials as the Secretary determines appropriate.
(2) ADDITIONAL MEMBERS.—If determined appropriate by
the Secretary, the Secretary may appoint to the Committee—
(A) parents or legal guardians of individuals with
autism or other pervasive developmental disorders; and
(B) representatives of other governmental agencies that
serve children with autism such as the Department of
Education.
(c) ADMINISTRATIVE SUPPORT; TERMS OF SERVICE; OTHER PROVISIONS.
—The following shall apply with respect to the Committee:
(1) The Committee shall receive necessary and appropriate
administrative support from the Department of Health and
Human Services.
(2) Members of the Committee appointed under subsection
(b)(2)(A) shall serve for a term of 3 years, and may serve
for an unlimited number of terms if reappointed.
(3) The Committee shall meet not less than two times
each year.
SEC. 105. REPORT TO CONGRESS.
Not later than January 1, 2001, and each January 1 thereafter,
the Secretary shall prepare and submit to the appropriate committees
of Congress, a report concerning the implementation of this
title and the amendments made by this title.
Deadline.
42 USC 247b–4e.
42 USC 247b–4d.
| File Type | application/msword |
| File Title | 114 STAT |
| Author | Paige K. Gallito |
| Last Modified By | dcs6 |
| File Modified | 2010-10-17 |
| File Created | 2010-10-17 |